Congratulations to the team of Barbara Lupo, Francesco Sassi, Marika Pinnelli, Francesco Galimi, Eugenia R. Zanella, Valentina Vurchio, Giorgia Migliardi, Paolo Armando Gagliardi, Alberto Puliafito, Daria Manganaro, Paolo Luraghi, Michael Kragh, Mikkel W. Pedersen, Ivan D. Horak, Carla Boccaccio, Enzo Medico, Luca Primo, Daniel Nichol, Inmaculada Spiteri, Timon Heide, Alexandra Vatsiou, Trevor A. Graham, Elena Élez, Guillem Argiles, Paolo Nuciforo, Andrea Sottoriva, Rodrigo Dienstmann, Diego Pasini, Elena Grassi, Claudio Isella, Andrea Bertotti and Livio Trusolino for their recent publication in Science Translational Medicine. The paper [...]
This month we feature our partners at HalioDx. HalioDx (https://www.haliodx.com/) is the pioneer of immuno-oncology diagnostic, a transforming approach of cancer care that benefits from novel and deep understanding of the tumour immune microenvironment. The company provides a unique and extensive range of proprietary assays that allow it to extract from the immune contexture of [...]
Hear ye! Hear ye! The Spring 2020 COLOSSUS newsletter is out now! Read the latest update on the COLOSSUS translational study from partners at Cancer Trials Ireland, a spotlight feature on our partner HalioDx, the dissemination round-up and much more!
VHIO hosts interactive public meeting drawing together stakeholders in colorectal cancer treatment and care
Principal Investigators (PIs) involved in the COLOSSUS and MoTriColor projects hosted a packed public meeting for people with colorectal cancer, their carers, and relatives on February 27, 2020, at the Vall d´Hebron Institute of Oncology in Barcelona. Berta Colldeforns Riera of VHIO, one of the co-organizers of this interactive event reported: "Everyone seemed very interested [...]
COLOSSUS teams up with MoTriColor for February 27th event “Advances and new horizons in the diagnosis and treatment of colorectal cancer”
In advance of the launch of Colorectal Cancer Awareness Month (March) 2020, COLOSSUS partners at VHIO have organized a special public event on Thursday, the 27th of February, from 18:00h-20:00h, at C/Rosselló, 231, 2-1 in Barcelona. Download the promotional flyer in PDF here: What is changing in the diagnosis and treatment of CRC_ (003) As [...]
Congratulations to authors Wolf H.Fridman, Ian Miller, CatherineSautès-Fridman, and Annette T.Byrne for their most recent paper published in Volume 158, Issue 2 edition of Gastroenterology dated January 2020, (pages 303-321). The open-access review is entitled: Therapeutic Targeting of the Colorectal Tumor Stroma.
COLOSSUS featured in the Cancer Trials Ireland publication, Winter 2019 DSSG Digest. You can download the full report here: http://bit.ly/2OvqN7G
Congratulations to all researchers involved in two COLOSSUS-acknowledged publications! The first, Immunogenomics of Colorectal Tumors: Facts and Hypotheses on an Evolving Saga, appears in the December 2019 edition of Trends in Cancer. The piece was authored by the team of Irene Catalano, Elena Grassi, Andrea Bertotti, and Livio Trusolino of the Universita degli Studi di [...]
Congratulations to Coordinator Prof Annette Byrne, RCSI for her recent HRB Investigator-Led Projects Award
Professor Annette Byrne was one of eight RCSI researchers to have been awarded a total of €2.8m in the 2019 Health Research Board (HRB) Investigator-Led Projects funding programme. Congratulations, Annette! The HRB Investigator-Led Projects scheme aims to support highly innovative and internationally competitive research, driven by a vision for improvements in human health and wellbeing. [...]
Pictured (from L to R) Iosune Baraibar, medical oncologist; Mireia Sanchis, Project Manager; Ariadna Garcia, Research Nurse; Javier Ros, Medical Oncologist; Javier Gonzalo, Project Manager* On November 5, 2019, Dr Rodrigo Dienstmann and the colorectal cancer clinical research team under the leadership of Dr Elena Elez at Vall d'Hebron Institute of Oncology have registered the first person in Spain for [...]